Immunotherapy. 2012;4(9):939-945. Potential reasons for the observed improvement in outcomes in vehicle groups include the natural regression of AK lesions, variation in investigator-determined ...

Once daily, 1 week AK lesion reduction from baseline: 28.8 Complete clearance: 0 AK lesion reduction from baseline: 62.6 Complete clearance: 18.1 <0.001 <0.001 In 5-FU group application, site ...

Clinicians use 5-fluorouracil (5-FU) as a first-line drug for colon, rectal, and pancreatic cancers. It's usually given in combination with oxaliplatin or irinotecan, which damage DNA in cancer cells.

Postoperative radiotherapy combined with 5-fluorouracil (5-FU) treatment improves outcome in rectal cancer. Some studies have suggested superiority for protracted venous infusion (PVI) of 5-FU ...